NRX Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.084; its P/E ratio is -0.74; NRX Pharmaceuticals is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -4.43M	$ -7.38M	$ -11.05M	$ -9.71M	$ -9.08M
EBITDA	$ -4.42M	$ -7.38M	$ -11.05M	$ -9.71M	$ -9.08M
Net Income Common Stockholders	$ -4.33M	$ -7.39M	$ -11.05M	$ -10.24M	$ -9.08M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 4.59M	$ 14.97M	$ 16.51M	$ 20.05M	$ 18.25M
Total Assets	$ 7.32M	$ 19.81M	$ 21.78M	$ 25.82M	$ 24.82M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -4.59M	$ -14.97M	$ -16.51M	$ -20.05M	$ -18.25M
Total Liabilities	$ 19.05M	$ 22.62M	$ 22.06M	$ 18.41M	$ 8.04M
Stockholders Equity	$ -11.73M	$ -2.81M	$ -284.00K	$ 7.41M	$ 16.78M
Cash Flow	-
Free Cash Flow	$ -3.19M	$ -7.81M	$ -6.09M	$ -8.32M	$ -6.27M
Operating Cash Flow	$ -3.19M	$ -7.81M	$ -6.09M	$ -8.32M	$ -6.27M
Investing Cash Flow	$ 1.00K	$ 2.00K	$ -4.00K	$ 1.00K	$ -5.00K
Financing Cash Flow	$ -1.12M	$ 6.27M	$ 2.54M	$ 10.12M	$ -28.00K

Currency in USD

NRX Pharmaceuticals Earnings and Revenue History

Income Statement >

NRX Pharmaceuticals Debt to Assets

Balance Sheet >

NRX Pharmaceuticals Cash Flow

Cash Flow >

NRX Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing